Le Lézard
Classified in: Health, Science and technology
Subject: PDT

VivaLNK Announces Developers Program for New eSkin Technology


SANTA CLARA, Calif., Dec. 17, 2017 /PRNewswire/ -- VivaLNK announces Vital Scout, a wellness assessment patch for medical grade accuracy not seen before with wrist worn devices. The Vital Scout uses electrocardiography (ECG) and 3D accelerometer sensors to monitor Heart Rate (HR), Respiration Rate (RR), and Heart Rate Variability (HRV) with specialized algorithms to determine your level of stress, recovery, duration and quality of sleep as well as activity/exercise intensity.

Vital Scout uses ECG sensors to provide more accurate readings of HR & RR in comparison to wrist-worn devices, which commonly use optical photoplethysmography (PPG) sensors. What's really unique about the Vital Scout patch is the lifestyle management application, which provides actionable insights.  The company is targeting this device to be sold to wellness professionals with the goal of making changes to improve health of their clients.  Unlike wrist worn devices, the patch could be worn for shorter periods of time (24-72 hours) yet provide more accurate meaningful data to review and take action.  

No need to be hooked up to wires or wear tight straps across the body, about the size of a band-aid the Vital Scout patch is the smallest wearable patch currently out on the market. Worn over the chest with adhesives, users can easily go about their daily activities with comfort. With up to 72 hr of continuous monitoring wellness professionals can work with their clients to (1) pinpoint areas of improvement, (2) set wellness goals, (3) follow up to see if the change in habits are effective and (4) encourage behavioral changes.

VivaLNK has been working closely with health analytics companies, and cardiac specialists over the years to develop Vital Scout, which would be available for wellness companies and professionals by the end of Q1 2018.  

Due to great interest for reliable biometric data VivaLNK is open to connecting with businesses in the Health and Wellness space by creating a developers program so that  developers can interact with Vital Scout data in their own application, products and services. To learn more about their API and enroll into VivaLNK's Developers Program you can visit the following link Link To Enroll into the Vital Scout's Developers Program.

Also for those attending CES in Las Vegas, VivaLNK will be revealing Vital Scout's new design and features. VivaLNK invites visitors to see the live demo of Vital Scout taking place in Sands/Venetian Expo Hall A-D Booth #43740. Link to Schedule Live Demo of Vital Scout at CES

About VivaLNK

VivaLNK, Inc. utilizes their patented eSkinTM technology, which is a circuit board that is as thin as your skin. It's a thin electronic substrate comfortable to wear, breathable, non-invasive and used as a platform for sensor integration and data services. VivaLNK is also the company behind Fever Scout the wearable smart thermometer patch that continuously sends data to your smartphone and alerts you of fever spikes. For more information, visit www.vivalnk.com and follow us on Twitter at @Viva_Lnk.

Contact:
Lucia Nguyen
1-408-829-8561
[email protected]

Maximizing comfort and accuracy Vital Scout is a wireless wearable patch that uses ECG, 3D accelerometer sensors to gather Heart Rate (HR) and Respiratory Rate (RR) data for medical-grade accuracy.

SOURCE VivaLNK


These press releases may also interest you

at 06:21
Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for sustainability and humanitarianism, today announced the deployment of AI-powered mammography services across Costa Rica to support the...

at 06:18
Surrey FA and Chelsea FC Foundation are proud to announce their collaborative effort once again to offer empowering coaching sessions to female refugees in the local community. These sessions will provide an opportunity for women to engage with...

at 06:05
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....

at 06:05
Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...

at 06:05
SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami. The Midas Digital Press 3D Printer is poised to not only transform dental...

at 06:00
Panacea Healthcare Solutions,...



News published on and distributed by: